Abstract
(1) Eleven depressive patients and one normal subject received 0.25 mg of salbutamol intravenously as part of a study of the antidepressant properties of this beta-2 adrenergic agonist. (2) No change whatsoever in the serum prolactin levels was observed after the salbutamol injection, indicating lack of involvement of beta-2 adrenergic receptor activation in the control of prolactin secretion.
Original language | English |
---|---|
Pages (from-to) | 177-179 |
Number of pages | 3 |
Journal | Psychoneuroendocrinology |
Volume | 6 |
Issue number | 2 |
DOIs | |
State | Published - 1 Jan 1981 |
Externally published | Yes |
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Endocrinology
- Endocrine and Autonomic Systems
- Psychiatry and Mental health
- Biological Psychiatry